Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  The Lancet

• Publication date

  2007-03-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(07)60411-5PMID 17350452
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ENHANCE: Results of a global open-label trial of drotrecogin alfa (activated) in children with severe sepsis*

  2006cited by this paper
• International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics*

  2005cited by this paper
• Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment*

  2005cited by this paper
• Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death.

  2005cited by this paper
• Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation 1

  2004cited by this paper
• Sources of variability on the estimate of treatment effect in the PROWESS trial: Implications for the design and conduct of future studies in severe sepsis*

  2004cited by this paper
• Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis.

  2004cited by this paper
• Fresh whole blood versus reconstituted blood for pump priming in heart surgery in infants.

  2004cited by this paper
• The epidemiology of severe sepsis in children in the United States.

  2003cited by this paper
• Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care

  2001cited by this paper
• Septic shock.

  2001cited by this paper
• Efficacy and safety of recombinant human activated protein C for severe sepsis.

  2001cited by this paper
• Sepsis in neonates and children: Definitions, epidemiology, and outcome

  1997cited by this paper
• Advances in the therapy for sepsis in children.

  1997cited by this paper
• Age-related Differences in Outcome and Severity of DIC in Children with Septic Shock and Purpura

  1996cited by this paper
• PRISM III: an updated Pediatric Risk of Mortality score.

  1996cited by this paper

• Burden and outcomes of pediatric acute respiratory distress syndrome among children with sepsis: a cohort study.

  2026cites this paper
• Evolution of Clinical Trials in Anticoagulation for Sepsis: Bridging Past to Future

  2025cites this paper
• Sepsis: the evolution of molecular pathogenesis concepts and clinical management

  2025cites this paper
• Protein C in adult patients with sepsis: from pathophysiology to monitoring and supplementation

  2025cites this paper
• Postresuscitation platelet transfusion in major trauma patients

  2025cites this paper
• Advances and Challenges in Pediatric Sepsis Diagnosis: Integrating Early Warning Scores and Biomarkers for Improved Prognosis

  2025cites this paper
• First report of a fatal case of Clostridium porci bacteremia in an 8-month-old girl presenting with purpura fulminans associated with concurrent Yersinia pseudotuberculosis infection.

  2025cites this paper
• Dabigatran prevents lipopolysaccharide mediated apoptosis in zebrafish through a thrombin independent mechanism

  2025cites this paper
• Thrombocytopenia in critically ill trauma patients is associated with the pattern and duration of postinjury organ dysfunction

  2025cites this paper
• Identification and transcriptomic assessment of latent profile pediatric septic shock phenotypes

  2024cites this paper
• Heparin in sepsis: current clinical findings and possible mechanisms

  2024cites this paper
• Vascular leak in sepsis: physiological basis and potential therapeutic advances

  2024cites this paper
• Endothelial dysfunction and immunothrombosis in sepsis

  2023cites this paper
• Anticoagulant therapies against sepsis‐induced disseminated intravascular coagulation

  2023cites this paper
• Safety and efficacy of artesunate treatment in severely injured patients with traumatic hemorrhage. The TOP-ART randomized clinical trial

  2023cites this paper
• A systematic review on de-escalation of antibiotics uses in surgical patients in clinical sepsis

  2023cites this paper
• New plasma protein C and protein S concentrate: A synergy for therapeutic purposes

  2023cites this paper
• Why anticoagulant studies on sepsis fail frequently --- start with SCARLET

  2023cites this paper
• Pediatric Sepsis Research: Where Are We and Where Are We Going?

  2022cites this paper
• Functional Outcomes in Survivors of Pediatric Sepsis: A Scoping Review and Discussion of Implications for Low- and Middle-Income Countries

  2022cites this paper
• Chasing the Ghost: Hyperinflammation Does Not Cause Sepsis

  2022cites this paper
• Protein C Pathway in Paediatric and Neonatal Sepsis

  2022influential citation
• Pediatric Organ Dysfunction Information Update Mandate (PODIUM) Contemporary Organ Dysfunction Criteria: Executive Summary.

  2022cites this paper
• Intracranial Bleeding as a Major Problem Among Neonates With Disseminated Intravascular Coagulation After the Introduction of Recombinant Thrombomodulin

  2022cites this paper
• Hemostasis Proteins in Invasive Meningococcal and Nonmeningococcal Infections: A Prospective Multicenter Study

  2022cites this paper
• Sepsis, Cytokine Storms, and Immunopathology: The Divide

  2021cites this paper
• Novel prenatal diagnosis of protein C deficiency and primary prophylaxis with protein C concentrate.

  2021cites this paper
• Old drug, new Trick? The rationale for the treatment of COVID-19 with activated protein C

  2021cites this paper
• Diagnostic Scores and Treatment Options for Acute Disseminated Intravascular Coagulation in Children

  2021cites this paper
• Sepsis, Cytokine Storms, and Immunopathology: The Divide between Neonates and Adults

  2021cites this paper
• Metabolic resuscitation in pediatric sepsis: a narrative review

  2021cites this paper
• Comparison of Interleukin-6 Plasma Concentration in Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Pediatric Sepsis

  2021cites this paper
• Co-Evolutions of Pediatric and Adult Critical Care.

  2021cites this paper
• Signaling pathways and intervention therapies in sepsis

  2021cites this paper
• Functional Outcomes at 1 Year After PICU Discharge in Critically Ill Children With Severe Sepsis.

  2020cites this paper
• Risk of Mortality in Immunocompromised Children With Severe Sepsis and Septic Shock

  2020cites this paper
• Childhood Obesity, Endothelial Cell Activation, and Critical Illness

  2020cites this paper
• Critical Illness Factors Associated With Long-Term Mortality and Health-Related Quality of Life Morbidity Following Community-Acquired Pediatric Septic Shock*

  2020cites this paper
• Pediatric infection and sepsis in five age subgroups: single-center registry

  2020cites this paper
• Proprotein Convertase Subtilisin/Kexin Type 9 Loss-of-Function Is Detrimental to the Juvenile Host With Septic Shock*

  2020cites this paper
• Infections à méningocoques

  2020cites this paper
• Sometimes more is not always better: ScvO2 monitoring in pediatric sepsis

  2020cites this paper
• Selective modulation of monocyte and neutrophil responses with activated protein C in preterm infants

  2020cites this paper
• Endothelial Responses in Sepsis.

  2020cites this paper
• Réponse de l’endothélium microvasculaire à l’inflammation aiguë

  2020cites this paper
• Protein C

  2020cites this paper
• Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies.

  2020cites this paper
• Recombinant human thrombomodulin attenuated sepsis severity in a non-surgical preterm mouse model

  2020cites this paper
• Early Axonal Injury and Delayed Cytotoxic Cerebral Edema are Associated With Microglial Activation in a Mouse Model of Sepsis.

  2019cites this paper
• Cutaneous Manifestations of Gram‐negative Infections

  2019cites this paper
• [Value of three scoring systems in evaluating the prognosis of children with severe sepsis].

  2019cites this paper
• Global Case-Fatality Rates in Pediatric Severe Sepsis and Septic Shock: A Systematic Review and Meta-analysis

  2019cites this paper
• Púrpura fulminante

  2019cites this paper
• Parents’ prioritised outcomes for trials investigating treatments for paediatric severe infection: a qualitative synthesis

  2019cites this paper
• Clinical Update in Pediatric Sepsis: Focus on Children With Pre-Existing Heart Disease.

  2019cites this paper
• Precision medicine in pediatric sepsis

  2019cites this paper
• Sepsis associated Acute Kidney Injury: incidence, risk factors and continuous renal replacement therapies

  2019cites this paper
• Blood coagulation: a powerful bactericidal mechanism of human innate immunity

  2019cites this paper
• Managing sepsis‐associated coagulopathy remains an enigma

  2019cites this paper
• The Role of Parental Concerns in the Recognition of Sepsis in Children: A Literature Review

  2019cites this paper
• Pediatric Intensive Care: Immunomodulation With Activated Protein C ex vivo

  2019cites this paper
• Precision medicine in pediatric sepsis.

  2019cites this paper
• The Future of Critical Care Lies in Quality Improvement and Education

  2019cites this paper
• The Comparative Epidemiology of Pediatric Severe Sepsis

  2019cites this paper
• Evaluation of 3K3A-Activated Protein C to Treat Neonatal Hypoxic Ischemic Brain Injury in the Spiny Mouse

  2018cites this paper
• Blood Coagulation During Sepsis and Septic Shock: Is There Still Room for Anticoagulants?

  2018cites this paper
• 38 – Meningococcal Capsular Group A, C, W, and Y Conjugate Vaccines

  2018cites this paper
• Beyond Survival: Pediatric Critical Care Interventional Trial Outcome Measure Preferences of Families and Healthcare Professionals*

  2018cites this paper
• Immunomodulation to Prevent or Treat Neonatal Sepsis: Past, Present, and Future

  2018cites this paper
• Esmolol infusion in patients with septic shock and tachycardia: a prospective, single-arm, feasibility study

  2018cites this paper
• Circulating activated protein C levels are not increased in septic patients treated with recombinant human soluble thrombomodulin

  2018cites this paper
• The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016)

  2018cites this paper
• Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies

  2018cites this paper
• Management of Multiorgan Failure in Sepsis

  2018cites this paper
• Early fibrinogen concentrate therapy for major haemorrhage in trauma (E-FIT 1): results from a UK multi-centre, randomised, double blind, placebo-controlled pilot trial

  2018cites this paper
• Contributions of a survey and retrospective cohort study to the planning of a randomised controlled trial of corticosteroids in the treatment of paediatric septic shock

  2018cites this paper
• Estimating Pediatric Acute Respiratory Distress Syndrome Outcomes From Oxygenation Variables.

  2018cites this paper
• Chapter 33 – The Failing Myocardium in Sepsis

  2018cites this paper
• The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J‐SSCG 2016)

  2018cites this paper
• Immunology and Immunodeficiencies in Children

  2018cites this paper
• Handbook of Sepsis

  2018cites this paper
• Invasive Meningococcal Disease in the Vaccine Era

  2018cites this paper
• Sepsis and Pediatric Acute Respiratory Distress Syndrome

  2018cites this paper
• Epidemiology and Outcomes of Pediatric Multiple Organ Dysfunction Syndrome

  2017cites this paper
• Primary Outcome Measures in Pediatric Septic Shock Trials: A Systematic Review*

  2017cites this paper
• 遺伝子組み換え型ヒト可溶性トロンボモジュリンの敗血症性disseminated intravascular coagulation（DIC）における有効性の検討

  2017cites this paper
• Drug use in acute meningococcal

  2017cites this paper
• Novel Inflammatory and Immunomodulatory Mediators in Sepsis

  2017cites this paper
• Epidemiology of Bleeding in Critically Ill Children

  2017cites this paper
• New or Progressive Multiple Organ Dysfunction Syndrome in Pediatric Severe Sepsis: A Sepsis Phenotype With Higher Morbidity and Mortality.

  2017cites this paper
• New or Progressive Multiple Organ Dysfunction Syndrome in Pediatric Severe Sepsis: A Sepsis Phenotype With Higher Morbidity and Mortality

  2017cites this paper
• Endothelial Cell Function and Dysfunction in Critically Ill Children

  2017cites this paper
• Prediction of pediatric sepsis mortality within 1 h of intensive care admission

  2017cites this paper
• High Levels of Morbidity and Mortality Among Pediatric Hematopoietic Cell Transplant Recipients With Severe Sepsis: Insights From the Sepsis PRevalence, OUtcomes, and Therapies International Point Prevalence Study.

  2017cites this paper
• Microbial recognition and danger signals in sepsis and trauma.

  2017cites this paper
• Update on pediatric sepsis: a review

  2017cites this paper
• Sepsis bei Kindern

  2017cites this paper
• Purpura Fulminans: Mechanism and Management of Dysregulated Hemostasis.

  2017cites this paper
• To What Extent Are the Terminal Stages of Sepsis, Septic Shock, Systemic Inflammatory Response Syndrome, and Multiple Organ Dysfunction Syndrome Actually Driven by a Prion/Amyloid Form of Fibrin?

  2017cites this paper
• Use and Future Investigations of Recombinant and Plasma-Derived Coagulation and Anticoagulant Products in the Neonate.

  2016cites this paper